CeriBell Corp (CBLL) - Kapitalisasi marang bathi
The share price history of CeriBell, Inc. (CBLL) helps assess the effectiveness of the SaaS model for AI EEG monitors, which ensures a stable cash flow and high profitability. The current figure is -14.70. Positive momentum is supported by the planned expansion of portable system production and the modernization of workshops. However, export restrictions and semiconductor shortages are hindering the brand's expansion into new markets and slowing down service maintenance.
Rincian metrik komprehensif lan analitis CeriBell Corp (CBLL)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas CeriBell, Inc.|CBLL - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal CeriBell EEG|CBLL - Utang perusahaan|Rasio utang marang kapitalisasi buku CeriBell, Inc.|CBLL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CeriBell|Rasio jangkoan perantara ceribell.com
- indikator bathi lan kelipatan valuasi:
CBLL - Bathi resik|Prakiraan bathi perusahaan CeriBell, Inc.|CBLL - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep CeriBell Inc|CBLL - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CeriBell, Inc.|CBLL - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan CeriBell|CBLL - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ceribell.com|CBLL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CeriBell, Inc.
Analisis komprehensif perusahaan:ceribell.com
CeriBell, Inc. (CBLL) investments in human capital to expand EEG systems directly impact net income, forming the denominator of this ratio. The metric correlates current market capitalization with annual earnings, determining the cost of one dollar of profit and the business's level of maturity. The stability of this ratio confirms the asset's defensive qualities, filtering out speculative noise. P/E valuation analysis allows for the determination of the actual return on R&D investments.
Analisis perusahaan pesaing
Koefisien rega marang bathi biogen.com (BIIB)|Pangali P/E NBIX|RGC - Kapitalisasi marang bathi|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|Nilai perusahaan marang bathi resik ACAD|Xenon Pharmaceuticals - Pangali P/E|Periode bali modal bisnis vikingtherapeutics.com VKTX|SUPN: Pangali P/E|CPRX (Catalyst Pharma) - Rasio rega marang bathi|DNLI (Denali Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Harmony Corp HRMY|Rasio rega marang bathi Biohaven Ltd. (BHVN)|Rasio rega marang bathi AMLX (amylyx.com)|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc - Rasio rega marang bathi|AVXL: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|ALEC: Pangali P/E|ANNX - Periode bali modal bisnis|Rasio rega marang bathi Omeros Corp|Pangali rega marang bathi NGNE (Neurogene Inc)|Pangali P/E ACIU|Koefisien rega marang bathi Voyager Corp VYGR|Neumora Therapeutics - Koefisien rega marang bathi|Periode bali modal bisnis scilexholding.com (SCLX)|Tevogen Bio - Pangali P/E|Alpha Cognition (ACOG) - Koefisien rega marang bathi|CGTX: Pangali P/E|IKT (Inhibikase Pharma) - Rasio rega marang bathi|Rasio rega marang bathi Cassava Sciences, Inc.|Rasio rega marang bathi ASRT|Rasio rega marang bathi Coya Therapeutics, Inc. (COYA)|Rasio rega marang bathi VTGN (vistagen.com)|Rasio rega marang bathi Ovid Therapeutics OVID|ABOS: Pangali rega marang bathi|CervoMed Inc. - Pangali P/E|Kapitalisasi marang bathi Alterity Therapeutics|CLNN (clene.com) - Koefisien rega marang bathi|PepGen (PEPG) - Pangali P/E|Rasio rega marang bathi Jupiter Neurosciences|RLMD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|GRCE - Kapitalisasi marang bathi|Pangali P/E AIFF (Firefly Neuroscience)|KLTO - Koefisien rega marang bathi|NeuroSense Therapeutics, Ltd. - Pangali P/E|Kapitalisasi marang bathi Reviva Pharmaceuticals, Inc.|metaviatx.com (MTVA) - Rasio rega marang bathi|neuraxis.com - Nilai perusahaan marang bathi resik|HSDT (Helius Medical Technologies, Inc.) - Pangali P/E|Passage Bio Corp (PASG) - Periode bali modal bisnis|Pangali P/E NEUP|Rasio rega marang bathi NERV (Minerva)|Pangali P/E ATHA (Athira Pharma, Inc.)|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|ALZN - Rasio rega marang bathi|CYCN: Rasio rega marang bathi|protagenic.com (PTIX) - Rasio rega marang bathi|KTTA (Pasithea Therapeutics Corp.) - Rasio rega marang bathi|Koefisien rega marang bathi CRGT|ATXI: Nilai perusahaan marang bathi resik|Pangali P/E BCLI|Periode bali modal bisnis Cara Therapeutics Inc.|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|ELYM: Pangali rega marang bathi|Intra-Cellular - Pangali P/E|longboardpharma.com (LBPH) - Koefisien rega marang bathi|MRNS (Marinus Pharmaceuticals, Inc.) - Koefisien rega marang bathi|NKGN - Periode bali modal bisnis|NRBO (NeuroBo) - Pangali P/E|Koefisien rega marang bathi Sage Therapeutics Inc (SAGE)|Pangali P/E SNPX|Rasio rega marang bathi TRVN (trevena.com)|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|anewmeds.com - Rasio rega marang bathi|CERE - Rasio rega marang bathi
